Investors / Japan / OSAKA University Venture Capital
OSAKA University Venture Capital
Corporate VC · Suita, Japan · Asia Pacific
OSAKA University Venture Capital is a wholly owned subsidiary of Osaka University, established in 2014, that invests in and supports the commercialization of university research results. Beyond funding, it provides management support, business development, talent networking and industry-academia-government collaboration.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsuniversity spinoutsdeep techtechnology transferclimatehealthcareenergy
Your fit with OSAKA University Venture Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOSAKA University Venture Capital lists 45 checked portfolio companies on its own site and is named in 4 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (55%), AI & Machine Learning (15%) and Industrial & Manufacturing (13%). 91% of its companies are based in Japan. It invests most often alongside Global Brain, JIC Venture Growth Investments and DBJ Capital.
Counts come from funding rounds that name OSAKA University Venture Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not OSAKA University Venture Capital's whole history. Rounds on record name 4 companies; its own site lists 45. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundOSAKA University Venture Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 82th | 47 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 73th | 9% of companies confirmed by a round |
| Sector focus | 87th | 55% in its largest sector |
| Reach | 58th | 3 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 55% | 15% |
| AI & Machine Learning | 15% | 18% |
| Industrial & Manufacturing | 13% | 7% |
| Cybersecurity | 3% | 4% |
| Consumer | 3% | 3% |
| E-commerce & Marketplaces | 2% | 5% |
| Education | 2% | 7% |
| Enterprise Software | 2% | 8% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Global Brain | 6 |
| JIC Venture Growth Investments | 5 |
| DBJ Capital | 4 |
| Keio Innovation Initiative | 4 |
| Kobe University Capital | 4 |
| Kyoto University Innovation Capital | 4 |
| Mitsui Sumitomo Insurance Capital | 4 |
| MPower Partners | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers45100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare OSAKA University Venture Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with OSAKA University Venture Capital| Date | Company | Stage |
|---|---|---|
| 15 Sept 2026 | Series A | |
| 23 Apr 2026 | Series B | |
| 19 Mar 2026 | Series A |
Round details for OSAKA University Venture Capital
Amounts, full round histories and every co-investor in OSAKA University Venture Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
45 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| 3DC develops and manufactures advanced battery materials and technologies, including Graphene MesoSponge, a next-generation carbon material | Industrial & ManufacturingE-commerce & Marketplaces | Portfolio page | ||
| The company develops and commercializes non-viral gene-modified immune cell therapy for cancer treatment. | Healthcare & Biotech | Portfolio page | ||
| The company develops and manufactures microbial rapid testing equipment. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides eye tracking-based cognitive assessment technology and related products, including medical equipment and general apps. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| AIBTRUST provides medical data solutions and platforms for healthcare institutions and patients | Healthcare & Biotech | Portfolio page | ||
| AI Samurai provides patent application support services using AI technology | AI & Machine LearningLegal & Compliance | Portfolio page | ||
| Alpha Fusion develops targeted alpha therapy for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| Atransen Pharma develops innovative medicines for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| A-wave develops medical devices and digital solutions for healthcare | Healthcare & Biotech | Portfolio page | ||
| The company develops and promotes products for walking analysis and improvement, including a walking analysis counter called Dr Walkie Plus. | Healthcare & Biotech | Portfolio page | ||
| Bioworks develops and produces plant-based materials, including a bioplastic called PlaX | Mobility & LogisticsConsumer | Portfolio page | ||
| The company provides music distribution services and develops software for music and audio production. | Enterprise SoftwareMedia & Entertainment | Portfolio page | ||
| EX-Fusion develops and utilizes laser-based nuclear fusion technology for energy solutions and laser processing services. | EducationIndustrial & Manufacturing | Portfolio page | ||
| FunPep develops peptides for use in pharmaceuticals and cosmetics. | Healthcare & Biotech | Portfolio page | ||
| GAIA BioMedicine develops immunotherapy treatments for cancer, including a platform for NK-like cell therapy | Healthcare & Biotech | Portfolio page | ||
| The company develops new cancer treatment drugs using innovative technology | Healthcare & Biotech | Portfolio page | ||
| HULIX provides spatial AI solutions using LiDAR and 3D twin technology to analyze and track movement in various spaces | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Portfolio page | ||||
| Immunosense develops and utilizes a unique immune measurement method called GLEIA | Healthcare & Biotech | Portfolio page | ||
| J-Pharma develops innovative new drugs through SLC transporter creation, contributing to people's health and hope, particularly for unmet medical needs. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- ouvc.co.jp
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 7 Oct 2025
- Companies checked
- 45
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get OSAKA University Venture Capital's profile as data
Pull OSAKA University Venture Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/ouvc.co.jp
# also
GET /v1/firms/ouvc.co.jp/portfolio
GET /v1/firms/ouvc.co.jp/coinvestors
GET /v1/firms/ouvc.co.jp/news